The Impact of Diabetes Process and Outcome Quality Measures on Overall Survival in Patients with Co-morbid Colorectal Cancer

Overview

Journal J Cancer Surviv

Specialty Oncology

Date 2010 Aug 20

PMID 20721633

Citations 20

Authors

Elizabeth Y Chiao

Preethi V Nambi

Aanand D Naik

Affiliations

Soon will be listed here.

Abstract

Purpose: To evaluate the effect of prevalent diabetes mellitus (DM) and quality of diabetes process and outcome measures on overall survival in colorectal cancer (CRC) patients.

Patient And Methods: We conducted a retrospective cohort study among patients newly diagnosed with CRC. Kaplan-Meier analyses and Cox proportional hazard regression models were performed. Quality of diabetes process and outcomes measures in the year prior to CRC diagnosis were compared with those in the year after CRC diagnosis.

Results: Four hundred and seventy CRC patients were identified during the study period, including 122 (26%) patients with DM. Survival between diabetic and non-diabetic were not significantly different after stratifying by stage. In a multivariable model, only age (HR 1.04), stage 2 and 3 (HR 1.88), stage 4 (HR 4.26), and Deyo comorbidity score (HR 1.14) were significantly associated with increased risk of death. Overall, patients in this CRC cohort with DM had good to excellent diabetes quality of care in the year prior to diagnosis as evidenced by primary care and eye clinic visits, number of times diabetes intermediate outcomes were measured, and level of cholesterol (95.5 ± 29.74) and hemoglobin A1c (7.2% + 1.4) control. After CRC diagnosis, there was no significant change in these quality of care indices compared to the year prior.

Conclusions: Prevalent DM did not affect overall survival in this cohort of VA patients diagnosed with CRC. The quality of diabetes care prior to CRC diagnosis, which persisted after diagnosis, may have moderated the mortality effect of diabetes in this CRC cohort.

Citing Articles

A Comparative analysis of type 2 diabetes management quality indicators in cancer survivors.

Ko E, Lee S Asia Pac J Oncol Nurs. 2022; 9(11):100116.

PMID: 36158707 PMC: 9500516. DOI: 10.1016/j.apjon.2022.100116.

Glycemic Control for Colorectal Cancer Survivors Compared to Those without Cancer in the Dutch Primary Care for Type 2 Diabetes: A Prospective Cohort Study.

de Haan-Du J, Landman G, Kleefstra N, Schrijnders D, Manders M, Bos A Cancers (Basel). 2021; 13(11).

PMID: 34199595 PMC: 8199666. DOI: 10.3390/cancers13112767.

Colon cancer-associated transcript-1 enhances glucose metabolism and colon cancer cell activity in a high-glucose environment and .

Cui G, Huang Y, Feng W, Yao Y, Zhou H, Li X J Gastrointest Oncol. 2021; 11(6):1164-1185.

PMID: 33456991 PMC: 7807285. DOI: 10.21037/jgo-20-474.

Patterns of chronic disease management and health outcomes in a population-based cohort of Black women with breast cancer.

Doose M, Tsui J, Steinberg M, Xing C, Lin Y, Cantor J Cancer Causes Control. 2021; 32(2):157-168.

PMID: 33404907 PMC: 7837275. DOI: 10.1007/s10552-020-01370-5.

Body Mass Index and Weight Loss in Metastatic Colorectal Cancer in CALGB (Alliance)/SWOG 80405.

Guercio B, Zhang S, Venook A, Ou F, Niedzwiecki D, Lenz H JNCI Cancer Spectr. 2020; 4(3):pkaa024.

PMID: 33134818 PMC: 7590517. DOI: 10.1093/jncics/pkaa024.

References

Polednak A . Comorbid diabetes mellitus and risk of death after diagnosis of colorectal cancer: a population-based study. Cancer Detect Prev. 2006; 30(5):466-72. DOI: 10.1016/j.cdp.2006.07.003. View

La Vecchia C, Negri E, Decarli A, Franceschi S . Diabetes mellitus and colorectal cancer risk. Cancer Epidemiol Biomarkers Prev. 1998; 6(12):1007-10. View

Kerr E, Fleming B . Making performance indicators work: experiences of US Veterans Health Administration. BMJ. 2007; 335(7627):971-3. PMC: 2072029. DOI: 10.1136/bmj.39358.498889.94. View

Meyerhardt J, Catalano P, Haller D, Mayer R, Macdonald J, Benson 3rd A . Impact of diabetes mellitus on outcomes in patients with colon cancer. J Clin Oncol. 2003; 21(3):433-40. DOI: 10.1200/JCO.2003.07.125. View

Jha A, Perlin J, Kizer K, Dudley R . Effect of the transformation of the Veterans Affairs Health Care System on the quality of care. N Engl J Med. 2003; 348(22):2218-27. DOI: 10.1056/NEJMsa021899. View

Williams J, Walsh D, Jackson J . Colon carcinoma and diabetes mellitus. Cancer. 1984; 54(12):3070-1. DOI: 10.1002/1097-0142(19841215)54:12<3070::aid-cncr2820541243>3.0.co;2-n. View

Barone B, Yeh H, Snyder C, Peairs K, Stein K, Derr R . Long-term all-cause mortality in cancer patients with preexisting diabetes mellitus: a systematic review and meta-analysis. JAMA. 2008; 300(23):2754-64. PMC: 3093051. DOI: 10.1001/jama.2008.824. View

Siddiqui A, Spechler S, Huerta S, Dredar S, Little B, Cryer B . Elevated HbA1c is an independent predictor of aggressive clinical behavior in patients with colorectal cancer: a case-control study. Dig Dis Sci. 2008; 53(9):2486-94. DOI: 10.1007/s10620-008-0264-4. View

OMara B, Byers T, Schoenfeld E . Diabetes mellitus and cancer risk: a multisite case-control study. J Chronic Dis. 1985; 38(5):435-41. DOI: 10.1016/0021-9681(85)90139-0. View

10.

Nilsen T, Vatten L . Prospective study of colorectal cancer risk and physical activity, diabetes, blood glucose and BMI: exploring the hyperinsulinaemia hypothesis. Br J Cancer. 2001; 84(3):417-22. PMC: 2363734. DOI: 10.1054/bjoc.2000.1582. View

11.

Yancik R, Wesley M, Ries L, Havlik R, Long S, Edwards B . Comorbidity and age as predictors of risk for early mortality of male and female colon carcinoma patients: a population-based study. Cancer. 1998; 82(11):2123-34. View

12.

El-Serag H, Johnson M, Hachem C, Morgana R . Statins are associated with a reduced risk of hepatocellular carcinoma in a large cohort of patients with diabetes. Gastroenterology. 2009; 136(5):1601-8. PMC: 2677134. DOI: 10.1053/j.gastro.2009.01.053. View

13.

Keating N, Zaslavsky A, Herrinton L, Selby J, Wolf R, Ayanian J . Quality of diabetes care among cancer survivors with diabetes. Med Care. 2007; 45(9):869-75. DOI: 10.1097/MLR.0b013e31806728e9. View

14.

Deyo R, Cherkin D, Ciol M . Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol. 1992; 45(6):613-9. DOI: 10.1016/0895-4356(92)90133-8. View

15.

Gross C, Guo Z, McAvay G, Allore H, Young M, Tinetti M . Multimorbidity and survival in older persons with colorectal cancer. J Am Geriatr Soc. 2007; 54(12):1898-904. DOI: 10.1111/j.1532-5415.2006.00973.x. View

16.

Wattacheril J, Kramer J, Richardson P, Havemann B, Green L, Le A . Lagtimes in diagnosis and treatment of colorectal cancer: determinants and association with cancer stage and survival. Aliment Pharmacol Ther. 2008; 28(9):1166-74. PMC: 2596579. DOI: 10.1111/j.1365-2036.2008.03826.x. View

17.

La Vecchia C, DAvanzo B, Negri E, Franceschi S . History of selected diseases and the risk of colorectal cancer. Eur J Cancer. 1991; 27(5):582-6. DOI: 10.1016/0277-5379(91)90223-z. View

18.

Nattinger A, Gottlieb M, VEUM J, Yahnke D, Goodwin J . Geographic variation in the use of breast-conserving treatment for breast cancer. N Engl J Med. 1992; 326(17):1102-7. DOI: 10.1056/NEJM199204233261702. View

19.

Shonka N, Anderson J, Panwalkar A, Reed E, Steen P, Ganti A . Effect of diabetes mellitus on the epidemiology and outcomes of colon cancer. Med Oncol. 2007; 23(4):515-9. DOI: 10.1385/MO:23:4:515. View